Affiliation:
1. National Institute of Gastroenterology—IRCCS “Saverio de Bellis”, 70013 Castellana Grotte, Italy
2. Local Health Unit—Barletta-Andria-Trani, 76121 Barletta, Italy
Abstract
Background: Steatotic liver disease (SLD) is defined as a fat accumulation in more than 5% of hepatocytes; it can progress to non-alcoholic steatohepatitis (NASH), associated with an increased state of inflammation. The aim of this study was to explore the protective effects of eating eggs and any association with SLD and hypertension (HTN). Methods: The study cohort included 908 participants assessed in the fourth recall of the MICOL study, grouped into four groups, based on NALFD and/or HTN. Results: The prevalence of HTN and SLD among participants was 31.61%. Overall, the results indicated a statistical significance of egg consumption, showing a protective role against the two disease conditions, in both the raw and adjusted models (RRR = 0.34, p = 0.009, 0.15 to 0.76 95% C.I.). Conclusions: Many differences were found among the groups, and the protective role of eating eggs was amply demonstrated. We can conclude that it is unwise to demonize the intake of this food and its nutritional properties, in contrast with previous reports in the literature.
Subject
Food Science,Nutrition and Dietetics
Reference53 articles.
1. Non-alcoholic fatty liver disease;Powell;Lancet,2021
2. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention;Younossi;Nat. Rev. Gastroenterol. Hepatol.,2018
3. (2019, October 05). Obesity epidemic results in Non-Alcoholic Fatty Liver Disease (NAFLD) becoming the most common cause of liver disease in Europe. EASL-The Home of Hepatology. Available online: https://www.ansa.it/pressrelease/english/2019/09/26/obesity-epidemic-results-in-non-alcoholic-fatty-liver-disease-nafld-becoming-the-most-common-cause_510e3913-3e9c-4d6a-bdd9-3edfec16c102.html.
4. Non alcoholic fatty liver: Epidemiology and natural history;Masarone;Rev. Recent. Clin. Trials,2014
5. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome;Marchesini;Diabetes,2001